The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
Open accessAbstract
Several lines of evidence suggest that the excessive accumulation of extracellular matrix in the glomeruli of diabetic kidneys may be due to reactive intermediates forming between glucose and matrix proteins called advanced glycation end products (AGEs). Normal mice received AGE-modified mouse serum albumin i.p. for 4 weeks, and glomerular extracellular matrix, growth factor mRNA levels, and morphology were examined. We found that AGE induced an increase in glomerular extracellular matrix alpha 1(IV) collagen, laminin B1, and transforming growth factor beta 1 mRNA levels, as measured by competitive PCR, as well as glomerular hypertrophy. The AGE response was specific because the coadministration of an AGE inhibitor, aminoguanidine, reduced all these changes. We conclude that AGEs affected expression of genes implicated in diabetic kidney disease and may play a major role in nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Self-citationReichard, P., Nilsson, B.-Y., & Rosenqvist, U. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290502 · Cited by 1,202
Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., & Cerami, A. (1986) · Science · doi:10.1126/science.3487117 · Cited by 1,146
Self-citationAdvanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918
Self-citationYamamoto, T., Nakamura, T., Noble, N. A., Ruoslahti, E., & Border, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1814 · Cited by 830
Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., & Ross, R. (1990) · Cell · doi:10.1016/0092-8674(90)90448-n · Cited by 741
Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue Remodeling
Vlassara, H., Brownlee, M., Manogue, K. R., Dinarello, C. A., & Pasagian, A. (1988) · Science · doi:10.1126/science.3259727 · Cited by 597
Self-citationImmunochemical detection of advanced glycosylation end products in vivo.
Makita, Z., Vlassara, H., Cerami, A., & Bucala, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42741-x · Cited by 491
Self-citationSoulis-Liparota, T., Cooper, M., Papazoglou, D., Clarke, B., & Jerums, G. (1991) · Diabetes · doi:10.2337/diab.40.10.1328 · Cited by 447
Floege, J., Burns, M. W., Alpers, C. E., Yoshimura, A., Pritzl, P., Gordon, K., Seifert, R. A., Bowen-Pope, D. F., Couser, W. G., & Johnson, R. J. (1992) · Kidney International · doi:10.1038/ki.1992.42 · Cited by 404
Vlassara, H., Fuh, H., Makita, Z., Krungkrai, S., Cerami, A., & Bucala, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12043 · Cited by 377
Self-citationKirstein, M., Brett, J., Radoff, S., Ogawa, S., Stern, D., & Vlassara, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.9010 · Cited by 364
Self-citationMechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine
Edelstein, D., & Brownlee, M. (1992) · Diabetes · doi:10.2337/diab.41.1.26 · Cited by 360
Doi, T., Vlassara, H., Kirstein, M., Yamada, Y., Striker, G. E., & Striker, L. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2873 · Cited by 351
Self-citationKirstein, M., Aston, C., Hintz, R., & Vlassara, H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115879 · Cited by 265
Self-citationThe Extracellular Matrix in Diabetic Nephropathy
Ziyadeh, F. N. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80440-9 · Cited by 258
Skolnik, E. Y., Yang, Z., Makita, Z., Radoff, S., Kirstein, M., & Vlassara, H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.931 · Cited by 244
Self-citationIncreased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium
Ayo, S. H., Radnik, R. A., Glass, W. F., Garoni, J. A., Rampt, E. R., Appling, D. R., & Kreisberg, J. I. (1991) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1991.260.2.f185 · Cited by 241
Post-Translational Modifications of Proteins
Krishna, R. G., & Wold, F. (1993) · Methods in Protein Sequence Analysis · doi:10.1007/978-1-4899-1603-7_21 · Cited by 221
Miyata, S., & Monnier, V (1992) · Journal of Clinical Investigation · doi:10.1172/jci115690 · Cited by 218
Cagliero, E., Roth, T., Roy, S., & Lorenzi, M. (1991) · Diabetes · doi:10.2337/diab.40.1.102 · Cited by 177
Jaffer, F., Saunders, C., Shultz, P. J., Throckmorton, D. C., Weinshell, E., & Abboud, H. E. (1989) · PubMed Central · Cited by 116
Mean Glomerular Volume and Rate of Development of Diabetic Nephropathy
Bilous, R. W., Mauer, S. M., Sutherland, D. E. R., & Steffes, M. W. (1989) · Diabetes · doi:10.2337/diab.38.9.1142 · Cited by 116
Vlassara, H. (1992) · Diabetes · doi:10.2337/diab.41.2.s52 · Cited by 73
Self-citationPeten, E. P., Striker, L. J., Carome, M. A., Elliott, S. J., Yang, C., & Striker, G. E. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1571 · Cited by 70
Self-citationMesangial deposition of type I collagen in human glomerulosclerosis
Glick, A. D., Jacobson, H. R., & Haralson, M. A. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90057-a · Cited by 61
Relationship of glomerular hypertrophy and sclerosis: Studies in SV40 transgenic mice
Mackay, K., Striker, L. J., Stauffer, J. W., Agodoa, L. Y. C., & Striker, G. E. (1990) · Kidney International · doi:10.1038/ki.1990.41 · Cited by 54
Self-citation
Cited by
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Nowotny, K., Jung, T., Höhn, A., Weber, D., & Grune, T. (2015) · Biomolecules · doi:10.3390/biom5010194 · Cited by 1,095
“Moreover, AGE-induced expression of TGF was demonstrated in vitro [157,158] and as TGF 1 upregulation was associated with enhanced expression of ECM proteins this might be an explanation for glomerular hypertrophy in vivo [159].”
BackgroundDiabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB
Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Klöting, I., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2792 · Cited by 824
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Self-citationVlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
Self-citationGiri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 635
Metadata
- Authors
- Yang, C. W., Vlassara, H., Peten, E. P., He, C. J., Striker, G. E., & Striker, L. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-09-27
- Volume
- 91
- Issue
- 20
- Pages
- 9436-9440
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2087511197
- Cited by
- 294
- References
- 27
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.